(Reuters) – Drug developer Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to treat multiple sclerosis as it failed to meet the main and secondary goals.
(Reporting by Mariam Sunny in Bengaluru; Editing by Alan Barona)
Comments